CASTLE BIOSCIENCES, INC. Cash and Restricted Cash
CASTLE BIOSCIENCES, INC. (CSTL) had Cash and Restricted Cash of $62.12 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62.12M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $63.76M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $116.73M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85.56M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $62.12M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $63.76M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $116.73M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $85.56M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $82.23M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $89.69M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $119.71M 10-Q · filed 2026-07-30 | |
| 2024-09-30 | $94.96M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $85.57M 10-Q · filed 2025-08-04 | |
| 2024-03-31 | $82.95M 10-Q · filed 2025-05-05 | |
| 2023-12-31 | $98.84M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $91.22M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $95.87M 10-Q · filed 2024-08-05 | |
| 2023-03-31 | $114.82M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $122.95M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $134.18M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $273.17M 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $309.02M 10-Q · filed 2023-05-03 | |
| 2021-12-31 | $329.63M 10-K · filed 2025-02-27 | |
| 2021-09-30 | $363.18M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $368.34M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $406.98M 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $409.85M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $183.05M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $179.76M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $98.65M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $98.84M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $94.47M 10-Q · filed 2020-11-09 | $94.47M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $17.47M 10-Q · filed 2020-08-10 | $17.47M 10-Q · filed 2019-09-03 |
| 2019-03-31 | $16.23M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $4.48M 10-K · filed 2021-03-11 | $4.48M 10-Q · filed 2019-09-03 |
| 2018-09-30 | $3.28M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $5.21M 10-Q · filed 2019-09-03 | |
| 2017-12-31 | $1.21M 10-K · filed 2020-03-10 | $1.21M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |